Nivolumab With Ipilimumab for Small Cell Lung Cancer

July 6, 2017
Matthew D. Hellmann, MD

Matthew D. Hellmann, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the CheckMate-032 study, which explored nivolumab (Opdivo) with or without ipilimumab (Yervoy) for patients with small cell lung cancer (SCLC).